05:01:54 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2025-02-20 Bokslutskommuniké 2024
2024-11-21 Kvartalsrapport 2024-Q3
2024-08-22 Kvartalsrapport 2024-Q2
2024-05-24 X-dag ordinarie utdelning DIGN 0.00 SEK
2024-05-23 Årsstämma 2024
2024-05-23 Kvartalsrapport 2024-Q1
2024-03-12 Extra Bolagsstämma 2024
2024-02-15 Bokslutskommuniké 2023
2023-11-16 Kvartalsrapport 2023-Q3
2023-08-17 Kvartalsrapport 2023-Q2
2023-05-26 X-dag ordinarie utdelning DIGN 0.00 SEK
2023-05-25 Kvartalsrapport 2023-Q1
2023-05-25 Årsstämma 2023
2023-02-16 Bokslutskommuniké 2022
2022-11-17 Kvartalsrapport 2022-Q3
2022-08-18 Kvartalsrapport 2022-Q2
2022-05-20 X-dag ordinarie utdelning DIGN 0.00 SEK
2022-05-19 Årsstämma 2022
2022-05-19 Kvartalsrapport 2022-Q1
2022-02-17 Bokslutskommuniké 2021
2021-11-18 Kvartalsrapport 2021-Q3
2021-08-19 Kvartalsrapport 2021-Q2
2021-05-21 X-dag ordinarie utdelning DIGN 0.00 SEK
2021-05-20 Årsstämma 2021
2021-05-20 Kvartalsrapport 2021-Q1
2021-02-18 Bokslutskommuniké 2020
2021-01-11 Extra Bolagsstämma 2021
2020-11-19 Kvartalsrapport 2020-Q3
2020-08-20 Kvartalsrapport 2020-Q2
2020-06-26 X-dag ordinarie utdelning DIGN 0.00 SEK
2020-06-25 Årsstämma 2020
2020-05-28 Kvartalsrapport 2020-Q1
2020-02-25 Bokslutskommuniké 2019
2020-02-10 Extra Bolagsstämma 2019
2019-11-19 Kvartalsrapport 2019-Q3
2019-08-22 Kvartalsrapport 2019-Q2
2019-05-16 X-dag ordinarie utdelning DIGN 0.00 SEK
2019-05-16 Kvartalsrapport 2019-Q1
2019-05-15 Årsstämma 2019
2019-02-26 Bokslutskommuniké 2018
2018-11-27 Kvartalsrapport 2018-Q3
2018-08-21 Kvartalsrapport 2018-Q2
2018-05-22 Kvartalsrapport 2018-Q1
2018-04-27 X-dag ordinarie utdelning DIGN 0.00 SEK
2018-04-26 Årsstämma 2018
2018-02-22 Bokslutskommuniké 2017
2017-12-04 Extra Bolagsstämma 2017
2017-11-23 Kvartalsrapport 2017-Q3
2017-08-24 Kvartalsrapport 2017-Q2
2017-06-02 Årsstämma 2017
2017-05-24 Kvartalsrapport 2017-Q1
2017-02-23 Bokslutskommuniké 2016
2016-11-24 Kvartalsrapport 2016-Q3
2016-08-25 Kvartalsrapport 2016-Q2
2016-05-25 Kvartalsrapport 2016-Q1
2016-03-23 X-dag ordinarie utdelning DIGN 0.00 SEK
2016-03-22 Årsstämma 2016
2016-02-24 Bokslutskommuniké 2015
2015-11-25 Kvartalsrapport 2015-Q3
2015-08-26 Kvartalsrapport 2015-Q2
2015-05-27 Kvartalsrapport 2015-Q1
2015-05-19 X-dag ordinarie utdelning DIGN 0.00 SEK
2015-02-24 Bokslutskommuniké 2014
2014-11-25 Kvartalsrapport 2014-Q3
2014-08-26 Kvartalsrapport 2014-Q2
2014-05-20 Kvartalsrapport 2014-Q1
2014-05-19 X-dag ordinarie utdelning DIGN 0.00 SEK
2014-05-16 Årsstämma 2014
2014-03-04 Extra Bolagsstämma 2014
2014-02-27 Bokslutskommuniké 2013
2013-11-28 Kvartalsrapport 2013-Q3
2013-08-28 Kvartalsrapport 2013-Q2
2013-08-28 Extra Bolagsstämma 2013
2013-05-22 Kvartalsrapport 2013-Q1
2013-05-22 X-dag ordinarie utdelning DIGN 0.00 SEK
2013-05-21 Årsstämma 2013
2013-02-27 Bokslutskommuniké 2012
2012-11-28 Kvartalsrapport 2012-Q3
2012-10-30 Extra Bolagsstämma 2012
2012-09-28 Kapitalmarknadsdag 2012
2012-08-28 Kvartalsrapport 2012-Q2
2012-06-29 Årsstämma 2012
2012-05-28 Kvartalsrapport 2012-Q1
2012-02-27 Bokslutskommuniké 2011
2011-11-17 Kvartalsrapport 2011-Q3
2011-08-22 Kvartalsrapport 2011-Q2
2011-06-13 X-dag ordinarie utdelning DIGN 0.00 SEK
2011-06-10 Årsstämma 2011
2011-05-30 Kvartalsrapport 2011-Q1
2011-02-25 Bokslutskommuniké 2010
2010-11-18 Kvartalsrapport 2010-Q3
2010-08-19 Kvartalsrapport 2010-Q2
2010-06-21 X-dag ordinarie utdelning DIGN 0.00 SEK
2010-05-18 Kvartalsrapport 2010-Q1
2010-02-18 Bokslutskommuniké 2009
2009-12-21 Split DIGN 100:1
2009-11-18 Kvartalsrapport 2009-Q3

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
Dignitana är verksamt inom medicinteknik. Bolaget utvecklar, tillverkar och marknadsför medicinska hjälpmedel som primärt används som skalpkylningssystem vid cytostatikabehandling, vars syfte är att eliminera eller kraftigt reducera håravfall. Bolaget har global verksamhet främst inom Norden, Europa, Nordamerika och Asien. Dignitana grundades år 2007 och har sitt huvudkontor i Lund.
2023-08-17 07:00:00

Dignitana AB (http://www.dignitana.se/), manufacturer of The DigniCap® Scalp Cooling System, has expanded the agreement with oneservice (https://one-service.com/), to provide service and maintenance to European health care facilities offering the DigniCap Delta model of the DigniCap Scalp Cooling System.

As part of Dignitana's ongoing commitment to high-quality customer service, DigniCap Delta customers in Europe can now access the extensive oneservice network for installation, maintenance, technical support and repairs. oneservice, a global provider of specialty technical services, has worked with Dignitana since 2019, previously focusing their efforts on the legacy C3 device.  With the introduction of the DigniCap Delta model to Europe, health care providers in Italy, Germany, Spain, Sweden, and The United Kingdom are now utilizing the next generation in scalp cooling technology that is offered with the DigniCap Delta model. As initial warranties expire, these customers can purchase Service Level Agreements from Dignitana which will be administered by oneservice.

"The ability to offer service in the field means European customers now have access to rapid-response service with a high-level of expertise," said Catarina Löwenadler, CEO of Dignitana.  "As we work to efficiently to expand DigniCap availability, we know we can rely on the industry experts and state-of-the-art resources at oneservice for consistent, high-quality and excellent service."

"We are proud to expand the scope of our work with Dignitana, servicing a market with enormous potential, while also supporting quality of life for cancer patients," said Matthias Raquet, CEO of oneservice. "We enjoy working with new technologies such as the thermoelectric cooling system in DigniCap Delta that can positively impact the quality of life of patients undergoing chemotherapy and we look forward seeing more customers across Europe adopt this innovative technology."

Löwenadler added, "Excellent customer service is a top priority for Dignitana, where we see 94 percent of DigniCap patients surveyed state they would recommend DigniCap to others, and 75 percent report satisfaction with their DigniCap results.  With this expanded oneservice agreement, we continue to do all we can to support the patient's journey with dignity and respect."

Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented by a Swedish Oncology nurse in 1999 and has been available in Europe since 2001. DigniCap was the first scalp cooling system to be cleared by the US Food and Drug Administration and is used to minimize chemotherapy induced hair loss in patients with solid tumor cancers. The pivotal trial achieved clinically superior results, with 66.3 percent of patients keeping the majority of their hair while undergoing chemotherapy.

There are nearly 3.7 million new cancer diagnoses in Europe per year (WHO (http://www.euro.who.int/en/health-topics/noncommunicable-diseases/cancer/data-and-statistics)) and breast cancer is the most common cancer in European women with approximately 500,000 new diagnoses per year (European Breast Cancer Coalition (https://www.europadonna.org/breast-cancer-facs/)).